BSE · HINDBIO
Hindustan Bio Sciences Ltd.
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,685
of 5,084 stocks
▼ 161W
Peak #4,669 · 21 Sep 2026
A microcap name in Healthcare, Hindustan Bio Sciences Ltd. carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 12%.
Market Cap
7.38 Cr
P/E Ratio
90.00
P/B Ratio
8.89
ROE
-9.56%
ROCE
-2.46%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | Rs 0 | Rs 0 | 38.25 L | Rs 0 |
| Net Profit | -11.29 L | -11.66 L | 8.19 L | -5.85 L |
| EPS | 11.00 | 0.11 | 0.08 | 0.06 |
| Operating Profit | -11.29 L | -11.66 L | 8.24 L | -5.84 L |
Shareholding pattern
Promoter
12.19%
Public
87.81%
PUBLIC BREAKDOWN
Individuals
82.83%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 03 Mar 2023 | Other | Reduction of Capital |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.